Vanda Pharmaceuticals targets $1B revenue by 2030 with expanded psychiatry portfolio Vanda Pharmaceuticals targets $1B revenue by 2030 with expanded psychiatry portfolio Post ContentvndaRead More You might also be interested in reading The New Era of CRO BEGINS 🔥. February 14, 2025 In Mainstream ← Previous post Next post →